Lys Therapeutics
Latest round
- Seed
Last raised
- Nov 2022
Total raised
- $3.1M
Investors
- 1
About Lys Therapeutics
Lys Therapeutics SAS, based in France, develops innovative biotherapies targeting neurological diseases, focusing on restoring blood-brain barrier integrity through advanced monoclonal antibody treatments. Founded in 2021 by CEO Manuel Blanc, CFO Philippe Dujardin and Thibault Honegger, headquartered in Lyon, France, Lys Therapeutics SAS is dedicated to developing therapies for neurological disorders.00 mn from Bpifrance, Normandie Participations, France 2030 and Michael J. Fox Foundation, which will support its ongoing projects. Lys Therapeutics has executed a total of 3 deals since its inception, focusing primarily on advancing its flagship product. Lys Therapeutics specializes in innovative biotherapies for neurological conditions, with its lead product LYS241 being a first-in-class monoclonal antibody. LYS241 aims to mitigate neuroinflammation and neurodegeneration by inhibiting the binding of tissue plasminogen activator to NMDA receptors, preserving their function and halting neurotoxic pathways. The company’s focus is on Western European and North American markets, collaborating with healthcare providers and research institutions to ensure effective patient care. Lys Therapeutics generates revenue through strategic partnerships and grants aimed at advancing LYS241 through clinical development. Collaborations with research institutions, pharmaceutical companies, and organizations such as The Michael J. The company aims to introduce new products and expand its reach into additional markets as it continues to develop innovative treatments for neurological disorders.
Who invested in Lys Therapeutics
1 investor across 1 round
See all investors in Lys Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 14, 2022
Amount
$3.1M
Investors
Questions about Lys Therapeutics
Who invested in Lys Therapeutics?
Lys Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lys Therapeutics raised?
Lys Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Lys Therapeutics last raise money?
Lys Therapeutics's most recent round on record is a Seed, in Nov 2022.
What does Lys Therapeutics do?
Lys Therapeutics SAS, based in France, develops innovative biotherapies targeting neurological diseases, focusing on restoring blood-brain barrier integrity through advanced monoclonal antibody treatments.
Where is Lys Therapeutics headquartered?
Lys Therapeutics is headquartered in Lyon, France.
Which VCs invest in companies like Lys Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Lys Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Lys Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.